(IMUX) Immunic - Performance -18.6% in 12m
Compare IMUX with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-84.41%
#146 in Group
Rel. Strength
30.91%
#5498 in Universe
Total Return 12m
-18.55%
#61 in Group
Total Return 5y
-89.91%
#100 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -
26th Percentile in Group
12m Total Return: IMUX (-18.6%) vs XBI (-14%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
2.95% | 13.3% | 161% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
HLN NYSE Haleon |
12.6% | 32.2% | 49.3% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
AMGN NASDAQ Amgen |
-8.67% | -12.4% | 27.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
LONN SW Lonza |
15.8% | 12% | 33.5% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
BIM PA Biomerieux |
4.68% | 18.2% | -1.63% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
KMDA NASDAQ Kamada |
14.1% | 27.3% | -5.64% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
NBIX NASDAQ Neurocrine Biosciences |
21.4% | -17.2% | 1.88% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
ERF PA Eurofins Scientific SE |
22.4% | 0.59% | 8.05% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: IMUX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for IMUX
Total Return (including Dividends) | IMUX | XBI | S&P 500 |
---|---|---|---|
1 Month | 9.19% | 2.02% | 2.87% |
3 Months | 5.21% | -15.44% | -6.42% |
12 Months | -18.55% | -14.02% | 9.87% |
5 Years | -89.91% | -26.47% | 107.51% |
Trend Score (consistency of price movement) | IMUX | XBI | S&P 500 |
1 Month | 59.6% | 57% | 89.4% |
3 Months | -22.5% | -82.3% | -72% |
12 Months | -57.8% | -53.1% | 49.3% |
5 Years | -92.8% | -53.9% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #103 | 7.03% | 6.15% |
3 Month | #22 | 24.4% | 12.4% |
12 Month | #61 | -5.26% | -25.9% |
5 Years | #107 | -86.3% | -95.1% |
FAQs
Does IMUX Immunic outperforms the market?
No,
over the last 12 months IMUX made -18.55%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.02%.
Over the last 3 months IMUX made 5.21%, while XBI made -15.44%.
Over the last 3 months IMUX made 5.21%, while XBI made -15.44%.
Performance Comparison IMUX vs Indeces and Sectors
IMUX vs. Indices IMUX is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -11.7% | 6.32% | -12.7% | -28.4% |
US NASDAQ 100 | QQQ | -12.0% | 4.48% | -13.2% | -29.9% |
US Dow Jones Industrial 30 | DIA | -12.0% | 7.58% | -11.7% | -24.9% |
German DAX 40 | DAX | -13.9% | -10.1% | -38.3% | -43.6% |
Shanghai Shenzhen CSI 300 | CSI 300 | -12.4% | 2.92% | -12.0% | -24.2% |
Hongkong Hang Seng | HSI | -15.3% | -7.02% | -22.2% | -30.6% |
India NIFTY 50 | INDA | -9.35% | 6.91% | -14.6% | -20.9% |
Brasil Bovespa | EWZ | -13.8% | -2.34% | -22.0% | -12.1% |
IMUX vs. Sectors IMUX is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -11.9% | 5.52% | -18.9% | -38.9% |
Consumer Discretionary | XLY | -12.7% | 5.68% | -10.6% | -32.6% |
Consumer Staples | XLP | -11.4% | 7.17% | -19.7% | -26.1% |
Energy | XLE | -12.7% | 9.11% | -6.74% | -8.79% |
Financial | XLF | -12.4% | 3.62% | -18.6% | -40.1% |
Health Care | XLV | -7.95% | 13.6% | -7.51% | -12.6% |
Industrial | XLI | -13.3% | 1.81% | -13.7% | -28.5% |
Materials | XLB | -11.7% | 4.48% | -8.69% | -12.5% |
Real Estate | XLRE | -11.4% | 3.07% | -15.1% | -32.0% |
Technology | XLK | -12.6% | 2.45% | -10.5% | -25.6% |
Utilities | XLU | -12.8% | 3.57% | -20.5% | -34.5% |
Aerospace & Defense | XAR | -12.3% | -0.15% | -22.0% | -43.7% |
Biotech | XBI | -3.66% | 7.17% | 8.32% | -4.53% |
Homebuilder | XHB | -11.3% | 6.12% | 0.89% | -8.80% |
Retail | XRT | -11.9% | 5.60% | -6.45% | -14.2% |